Day One Biopharmaceuticals's total assets for Q1 2025 were $534.36M, a decrease of -8.31% from the previous quarter. DAWN total liabilities were $54.84M for the fiscal quarter, a -31.48% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.